Drug intelligence / Profile preview

recombinant human collagen gel

Development stage
Unknown
Lead developer
Winner Medical
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Recombinant human collagen gel is a topical therapeutic formulation containing collagen protein produced through recombinant DNA technology, typically using yeast (*Pichia pastoris*) or plant-based expression systems. Designed for wound management, particularly in partial-thickness burns, the gel serves as a bioactive scaffold that mimics the natural extracellular matrix. It facilitates wound healing by promoting the adhesion, migration, and proliferation of fibroblasts and keratinocytes through interactions with cell-surface receptors such as integrins and discoidin domain receptors. By using a recombinant human sequence, the product avoids the potential immunogenicity, bovine spongiform encephalopathy (BSE) risks, and batch-to-batch variability associated with traditional animal-derived collagen products. In clinical trials, it has been evaluated in comparison to biological dressings like xenografts (e.g., gene-transfected pigskin) to evaluate its efficacy in accelerating re-epithelialization and improving cosmetic outcomes.

Other names
recombinant human collagen dressingrhCollagen gelHuman-like Collagen gelrecombinant humanized collagen gel
02

Targets

ITGB1 (Integrin beta-1)DDR2 (Discoidin domain receptor tyrosine kinase 2)DDR1 (Discoidin domain receptor 1)ITGA2 (Integrin alpha-2)

Beyond the preview

Go deeper on recombinant human collagen gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant human collagen gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call